News Article

Global private equity healthcare specialist ARCHIMED has acquired FIM Medical, a leader in the vision, audio & respiratory medical devices market. Candesic provided ARCHIMED with commercial due diligence. The Candesic team, was led by Senior Partner Marc Kitten and supervised by Associate Dr Marco MAZEVET.

FIM Medical is the leader in the national French occupational health market across its primary product lines – vision testers, audiometers, and spirometers – and has successfully expanded across Europe and into the US. With a robust brand reputation and competitive edge, FIM Medical is a growing company poised for international expansion, both organically and through acquisitions.

ARCHIMED Partner Antoine Faguer commented that “FIM Medical is a valuable addition to the ARCHIMED portfolio, strengthening our presence into the neuro, sensory and occupational health sectors, which we already know well through our investments in Vita Health Group, Natus Medical Incorporated, AD-TECH and some others.”